Max Robotics — Global Service Robot Directory + US Certification

About

Kevin Keating is a urologic surgeon whose research focuses on minimally invasive and robotic-assisted approaches to complex urological conditions, including kidney cancer, stone disease, and upper tract malignancies. His work consistently advances the frontier of robotic surgery, demonstrating its feasibility and safety in scenarios traditionally requiring open operative techniques. Keating's most-cited contribution, "Robotic management of large stone disease" (2020, 8 citations), highlights his efforts to expand robotic applications in endourology. His research on inferior vena cava thrombectomy using Rummel Tourniquets showcases technical innovation in managing the challenging 4–10% of renal cell carcinoma cases with IVC involvement. He has also contributed meaningfully to kidney-sparing strategies, reporting a notable case of bilateral succinate dehydrogenase-deficient renal cell carcinoma—an exceptionally rare familial cancer subtype with fewer than 60 documented cases—successfully managed through staged robotic partial nephrectomies. Further broadening his portfolio, Keating has investigated low-pressure pneumoperitoneum in robotic prostatectomy through a rigorous prospective, randomized, double-blinded trial, reflecting his commitment to evidence-based surgical refinement. His body of work positions him as a clinician-innovator dedicated to improving patient outcomes through advanced robotic techniques across a spectrum of urological diseases.